COVID booster | sciencenewsnet.in

Breaking News

Continued Medicare Reimbursement Declines Could Threaten Access to Physicians

Rutgers Cancer Institute of New Jersey Researcher Elected to the American Academy of Arts and Sciences

Six RPI Students Receive Prestigious NSF Graduate Research Fellowships

ETRI Develops An Automated Benchmark for Language-based Task Planners

New Sodium-ion battery tech boosts green energy storage affordability

“Developing Thai Family Stability to Fight Human Crisis” Workshop

WHOI Physical Oceanographer publishes peer-reviewed book about the Indian Ocean

Research Finds Pronoun Use Not Only Shaped By Language But Also Beliefs

Divining peak groundwater

$2.7 million grant to explore hypoxia’s impact on blood stem cells

26 Apr, 2024

Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission

July 20, 2023 sarah JonasAnnouncement

The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.

Neutralizing antibodies from single COVID-19 booster steadily decline

September 7, 2022 sarah JonasResearch Results

Neutralizing antibody levels against the original COVID-19 virus and omicron variants in vaccinated adults tend to decline by at least 15% per month after a single booster shot, a new study using serum from human blood samples suggests.